SCHEMBL2230706

SCHEMBL2230706

CCCC[n+]1ccn(C)c1.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.47

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 4/20 0.47
HPGD P15428 2/20 0.44
MEN1 O00255 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
HTT P42858 2/20 0.40
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RXFP1 Q9HBX9 2/20 0.38
BLM P54132 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28365668 0.95 KDM4E (0.48) KDM4EALDH1A1HPGDMEN1CYP3A4
SCHEMBL7195917 0.95 KDM4E (0.48) KDM4EALDH1A1HPGDMEN1CYP3A4
SCHEMBL28026186 0.95 KDM4E (0.48) KDM4EALDH1A1HPGDMEN1CYP3A4
SCHEMBL14720657 0.95 KDM4E (0.48) KDM4EALDH1A1HPGDMEN1CYP3A4
SCHEMBL4457299 0.90 ALDH1A1 (0.47) KDM4EALDH1A1HPGDMEN1CYP3A4
SCHEMBL21173939 0.87 KDM4E (0.46) KDM4EALDH1A1HPGDMEN1CYP3A4
SCHEMBL52072 0.86 HTT (0.40) KDM4EALDH1A1HPGDMEN1CYP3A4
SCHEMBL16245999 0.86 ALDH1A1 (0.39) KDM4EALDH1A1HPGDMEN1CYP3A4
SCHEMBL2295676 0.86 KDM4E (0.47) KDM4EALDH1A1HPGDMEN1CYP3A4
SCHEMBL3027844 0.85 ALDH1A1 (0.36) KDM4EALDH1A1HPGDMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382408-A1 EPOXY-TERMINATED ISOCYANATE PREPOLYMERS, AND PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2025-12-18 US claimed
EP-4543955-A1 EPOXY-TERMINATED ISOCYANATE PREPOLYMERS, AND PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2025-04-30 EP claimed
CN-119823109-A An electrochromic material electrochromic composition and electrochromic device 吉林大学 2025-04-15 CN claimed
CN-119403855-A Epoxy blocked isocyanate prepolymer and method for producing same 巴斯夫欧洲公司 2025-02-07 CN claimed
EP-3470493-B1 COMPOSITIONS COMPRISING LATENT HEAT STORAGE MATERIALS PHASE CHANGE ENERGY SOLUTIONS INC (US) 2024-05-15 EP claimed
WO-2024081696-A2 COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME PHASE CHANGE ENERGY SOLUTIONS, INC. (US) 2024-04-18 WO claimed
CN-111117594-B Electrochromic material and electrochromic device based on dynamic metal-ligand complexation 吉林大学 2024-03-26 CN claimed
WO-2023247278-A1 EPOXY-TERMINATED ISOCYANATE PREPOLYMERS, AND PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2023-12-28 WO claimed
CN-115010836-B Electrochromic polymer, nano particle and device 吉林大学 2023-09-08 CN claimed
CN-114130165-B Recyclable ionic gel dehumidifying bag 中国科学院大连化学物理研究所 2023-03-24 CN claimed
EP-1869061-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY Combimatrix Corporation (US) 2007-12-26 EP claimed
US-20070293707-A1 Method for Separating Hydrogen Chloride and Phosgene BASF AKTIENGESELLSCHAFT (DE) 2007-12-20 US claimed
EP-1805206-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE Combimatrix Corporation (US) 2007-07-11 EP claimed
EP-1663921-B1 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AG (DE) 2007-05-02 EP claimed
WO-2007032022-A2 CONSOLIDATION OF NON-WOVEN TEXTILE FIBRES PREETI LODHA (IN) 2007-03-22 WO claimed
US-20070055084-A1 Method for producing haloalkanes from alcohols BASF AKTIENGESELLSCHAFT (DE) 2007-03-08 US claimed
US-20070034513-A1 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array COMBIMATRIX CORPORATION 2007-02-15 US claimed
WO-2006105037-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY COMBIMATRIX CORPORATION (US) 2006-10-05 WO claimed
WO-2006031814-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE COMBIMATRIX CORPORATION (US) 2006-03-23 WO claimed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293707-A1 Method for Separating Hydrogen Chloride and Phosgene PSPH, SLC9B2, HVCN1 KDM4E 4758/4885ALDH1A1 4716/4885HPGD 284/4885
US-20070055084-A1 Method for producing haloalkanes from alcohols ADH1C, HDHD5, ADH5 KDM4E 2710/4885ALDH1A1 493/4885HPGD 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.